BSE Live
Nov 28, 16:01Prev. Close
3115.30
Open Price
3118.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 28, 15:58Prev. Close
3114.50
Open Price
3121.90
Bid Price (Qty.)
3051.80 (57)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Dr Lal PathLabs (in Rs. Cr.) | Mar 15 | |
| 12 mths | ||
| INCOME | ||
| Revenue From Operations [Gross] | 659.59 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | |
| Revenue From Operations [Net] | 659.59 | |
| Total Operating Revenues | 659.59 | |
| Other Income | 2.95 | |
| Total Revenue | 662.54 | |
| EXPENSES | ||
| Cost Of Materials Consumed | 0.00 | |
| Purchase Of Stock-In Trade | 0.00 | |
| Operating And Direct Expenses | 139.16 | |
| Changes In Inventories Of FGWIP And Stock In Trade | 0.00 | |
| Employee Benefit Expenses | 134.39 | |
| Finance Costs | -9.00 | |
| Depreciation And Amortisation Expenses | 28.19 | |
| Other Expenses | 230.09 | |
| Total Expenses | 522.83 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 139.72 | |
| Exceptional Items | 0.00 | |
| Profit/Loss Before Tax | 139.72 | |
| Tax Expenses-Continued Operations | ||
| Current Tax | 50.50 | |
| Less: MAT Credit Entitlement | 0.00 | |
| Deferred Tax | -5.79 | |
| Other Direct Taxes | 0.00 | |
| Total Tax Expenses | 43.28 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 96.44 | |
| Profit/Loss From Continuing Operations | 96.44 | |
| Profit/Loss For The Period | 96.44 | |
| Minority Interest | -0.75 | |
| Consolidated Profit/Loss After MI And Associates | 95.68 | |
| OTHER ADDITIONAL INFORMATION | ||
| EARNINGS PER SHARE | ||
| Basic EPS (Rs.) | 17.00 | |
| Diluted EPS (Rs.) | 12.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||
| Equity Share Dividend | 12.46 | |
| Tax On Dividend | 2.65 |
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak